Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Hope springs for April inhibition
EP Vantage
Tue, 06/13/23 - 10:27 am
Novartis
Chinook Therapeutics
April inhibition
M&A
Vera Therapeutics
Otsuka
RemeGen
Alpine Immune Sciences
Akso Biopharmaceutical
Aurinia Pharmaceuticals
As Illumina’s deSouza departs, will Grail go next?
BioPharma Dive
Tue, 06/13/23 - 10:24 am
Illumina
Grail
Francis deSouza
M&A
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Fierce Pharma
Mon, 06/12/23 - 11:22 pm
Bayer
oncology
M&A
Novartis to acquire kidney disease biotech Chinook for up to $3.5B
BioPharma Dive
Mon, 06/12/23 - 10:24 am
Novartis
Chinook Therapeutics
M&A
kidney disease
Illumina Appeals FTC’s Ruling to Divest Grail
Medical Devices and Diagnostics Industry
Thu, 06/8/23 - 09:48 am
Illumina
FTC
Grail
M&A
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
BioSpace
Wed, 06/7/23 - 11:15 am
Amgen
Horizon Therapeutics
FTC
M&A
Antibiotic maker Paratek, low on cash, agrees to a buyout
BioPharma Dive
Tue, 06/6/23 - 04:17 pm
Paratek
antibiotics
M&A
Novo Nordisk Foundation
BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent
Fierce Biotech
Tue, 06/6/23 - 11:16 am
Jazz Pharmaceuticals
Bruce Cozadd
M&A
BIO 2023
neurology
oncology
Novo Nordisk enters talks to buy device maker Biocorp
Medical Marketing and Media
Mon, 06/5/23 - 11:30 am
Novo Nordisk
M&A
Medtech
Biocorp
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Fierce Pharma
Mon, 06/5/23 - 10:21 am
Amgen
Horizon Therapeutics
FTC
M&A
MEI Pharma CEO departs as company rejects unsolicited takeover bid
Medical Marketing and Media
Sun, 06/4/23 - 04:25 pm
MEI Pharma
Pharma CEOs
Daniel Gold
M&A
Concentra finds latest acquisition attempt harder to swallow as Atea rejects 'undervalued' offer
Fierce Biotech
Tue, 05/30/23 - 09:22 pm
Concerta Biosciences
M&A
Atea Pharmaceuticals
Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer
Fierce Pharma
Tue, 05/30/23 - 11:27 am
Sun Pharma
M&A
Taro Pharmaceuticals
India
Boston Sci Scraps Majority Stake Deal with M.I. Tech
Medical Devices and Diagnostics Industry
Mon, 05/29/23 - 12:07 pm
Medtech
Boston Scientific
M&A
MI Tech
Medtronic Is Sweet on EOFlow
Medical Devices and Diagnostics Industry
Thu, 05/25/23 - 12:46 pm
Medtronic
diabetes
Medtech
M&A
EOFlow
Purdue Pharma to sell consumer business for $397 mln
Reuters
Wed, 05/24/23 - 06:49 pm
Purdue Pharma
M&A
consumer health
Arcardia Consumer Healthcare
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
Wed, 05/24/23 - 11:18 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Astellas
Iveric Bio
Bayer
Amgen
M&A
Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea
Fierce Biotech
Mon, 05/22/23 - 09:58 pm
Concerta Biosciences
Atea Pharmaceuticals
M&A
COVID-19
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Motley Fool
Mon, 05/22/23 - 11:40 am
Pfizer
debt
Seagen
M&A
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »